Lista de obras -

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

artículo científico publicado en 2006

A community-based service enhancement model of training and employing Ear Health Facilitators to address the crisis in ear and hearing health of Aboriginal children in the Northern Territory, the Hearing for Learning Initiative (the HfLI): study pro

scientific article published in 2021

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

artículo científico publicado en 2012

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

artículo científico publicado en 2012

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care ⬇️

artículo científico publicado el 4 de agosto de 2011

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

artículo científico publicado en 2009

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria ⬇️

artículo científico publicado el 6 de octubre de 2011

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

artículo científico

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children ⬇️

artículo científico publicado en 2011

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

artículo científico publicado en 2011

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

artículo científico publicado en 2004

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

artículo científico publicado en 2011

Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial

artículo científico publicado en 2011

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure

artículo científico publicado en 2013

General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.

artículo científico publicado en 2016

Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras ⬇️

artículo científico publicado el 25 de septiembre de 2010

Hearing loss among Australian Aboriginal infants and toddlers: A systematic review

scientific article published in 2020

Impact of hearing impairment on early childhood development in Australian Aboriginal children: A data linkage study

artículo científico publicado en 2020

Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children

artículo científico publicado en 2009

Is early surgical referral for children with persistent otitis media with effusion (OME) appropriate? ⬇️

artículo científico publicado el 20 de octubre de 2003

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children

artículo científico

Low Genetic Diversity of Haemophilus influenzae Type b Compared to Nonencapsulated H. influenzae in a Population in Which H. influenzae Is Highly Endemic ⬇️

artículo científico publicado el 1 de julio de 1998

Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations

artículo científico publicado en 2021

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

artículo científico publicado en 2021

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

artículo científico publicado en 2005

Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials ⬇️

artículo científico publicado el 1 de diciembre de 2011

Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol

artículo científico publicado en 2023

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region ⬇️

artículo científico publicado el 8 de enero de 2013

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

artículo científico publicado en 2010

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial

artículo científico publicado en 2007

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

artículo científico publicado en 2007

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

artículo científico publicado en 2019

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial

artículo científico publicado en 2010

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

artículo científico publicado en 2016

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children

artículo científico publicado en 2011

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

artículo científico publicado en 2005

Viability of respiratory pathogens cultured from nasopharyngeal swabs stored for up to 12years at −70°C in skim milk tryptone glucose glycerol broth ⬇️

artículo científico publicado el 28 de junio de 2011

Lista de obras de

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.

A community-based service enhancement model of training and employing Ear Health Facilitators to address the crisis in ear and hearing health of Aboriginal children in the Northern Territory, the Hearing for Learning Initiative (the HfLI): study pro

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care ⬇️

Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya

Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria ⬇️

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children ⬇️

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure

General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.

Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine eras ⬇️

Hearing loss among Australian Aboriginal infants and toddlers: A systematic review

Impact of hearing impairment on early childhood development in Australian Aboriginal children: A data linkage study

Insights into long-lasting protection induced by RTS,S/AS02A malaria vaccine: further results from a phase IIb trial in Mozambican children

Is early surgical referral for children with persistent otitis media with effusion (OME) appropriate? ⬇️

Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children

Low Genetic Diversity of Haemophilus influenzae Type b Compared to Nonencapsulated H. influenzae in a Population in Which H. influenzae Is Highly Endemic ⬇️

Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya

Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials ⬇️

Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the ‘D-Kids’ study protocol

Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02D malaria vaccine in infants living in a malaria-endemic region ⬇️

Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trial

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Safety, immunogenicity and duration of protection of the RTS,S/AS02(D) malaria vaccine: one year follow-up of a randomized controlled phase I/IIb trial

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

Viability of respiratory pathogens cultured from nasopharyngeal swabs stored for up to 12years at −70°C in skim milk tryptone glucose glycerol broth ⬇️